Monday, December 19, 2016

BRIEF-Foundation Medicine receives FDA approval of Foundationfocus

* Foundation Medicine receives FDA approval of

Foundationfocus CDXBRCA as a companion diagnostic for

Rubraca(Rucaparib) for the treatment of women with ovarian

cancer

Source text for Eikon:

Further...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)